Literature DB >> 14518126

Synthesis and reactions of partially reduced biisoquinolines.

Mark C Elliott1, Eve Williams.   

Abstract

An improved synthesis of the 1,1',2,2',3,3',4,4'-octahydro-1.1'-biisoquinoline ring system is described. The reactivity of this system has been investigated, including the unusually high basicity of the parent compound and its N.N'-dimethyl derivative. The resolution of the parent compound has been achieved for the first time, along with the development of a straightforward method for assaying its enantiomeric purity.

Entities:  

Year:  2003        PMID: 14518126     DOI: 10.1039/b306159k

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  4 in total

1.  Enhanced Nrf2-dependent induction of glutathione in mouse embryonic fibroblasts by isoselenocyanate analog of sulforaphane.

Authors:  Sans W Emmert; Dhimant Desai; Shantu Amin; John P Richie
Journal:  Bioorg Med Chem Lett       Date:  2010-01-20       Impact factor: 2.823

2.  Facile Synthesis of Tricyclic 1,2,4-Oxadiazolines-Fused Tetrahydro-Isoquinolines from Oxime Chlorides with 3,4-Dihydroisoquinoline Imines.

Authors:  Kaikai Wang; Yanli Li; Wei Zhang; Rongxiang Chen; Xueji Ma; Mingyue Wang; Nan Zhou
Journal:  Molecules       Date:  2022-05-10       Impact factor: 4.927

3.  Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.

Authors:  Arun K Sharma; Arati Sharma; Dhimant Desai; SubbaRao V Madhunapantula; Sung Jin Huh; Gavin P Robertson; Shantu Amin
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

4.  Stereoselective, nitro-Mannich/lactamisation cascades for the direct synthesis of heavily decorated 5-nitropiperidin-2-ones and related heterocycles.

Authors:  Pavol Jakubec; Dane M Cockfield; Madeleine Helliwell; James Raftery; Darren J Dixon
Journal:  Beilstein J Org Chem       Date:  2012-04-16       Impact factor: 2.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.